[1]
“Renin-angiotensin-aldosterone system inhibitors – a realm of confusion in COVID-19”, J Ideas Health, vol. 4, no. Special2, pp. 389–394, Jul. 2021, doi: 10.47108/jidhealth.Vol4.IssSpecial2.125.